Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Application of IL-2 therapy to target T regulatory cell function.

Shevach EM.

Trends Immunol. 2012 Dec;33(12):626-32. doi: 10.1016/j.it.2012.07.007. Epub 2012 Aug 30. Review.

2.

Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera.

Votavova P, Tomala J, Kovar M.

Immunol Lett. 2014 May-Jun;159(1-2):1-10. doi: 10.1016/j.imlet.2014.01.017. Epub 2014 Feb 7. Review.

PMID:
24512738
3.

IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.

Shameli A, Yamanouchi J, Tsai S, Yang Y, Clemente-Casares X, Moore A, Serra P, Santamaria P.

Eur J Immunol. 2013 Feb;43(2):394-403. doi: 10.1002/eji.201242845. Epub 2013 Jan 15.

4.

CD4+CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2 homeostasis.

McNally A, Hill GR, Sparwasser T, Thomas R, Steptoe RJ.

Proc Natl Acad Sci U S A. 2011 May 3;108(18):7529-34. doi: 10.1073/pnas.1103782108. Epub 2011 Apr 18.

5.

IL-2-independent generation of FOXP3(+)CD4(+)CD8(+)CD25(+) cytotoxic regulatory T cell lines from human umbilical cord blood.

Nakamura S, Suzuki M, Sugimoto A, Tsuji-Takayama K, Yamamoto M, Otani T, Inoue T, Harashima A, Okochi A, Motoda R, Yamasaki F, Orita K, Kibata M.

Exp Hematol. 2007 Feb;35(2):287-96.

PMID:
17258077
6.

Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cells.

Sun L, Hurez VJ, Thibodeaux SR, Kious MJ, Liu A, Lin P, Murthy K, Pandeswara S, Shin T, Curiel TJ.

Aging Cell. 2012 Jun;11(3):509-19. doi: 10.1111/j.1474-9726.2012.00812.x. Epub 2012 Mar 22.

7.

IL-15-dependent CD8+ CD122+ T cells ameliorate experimental autoimmune encephalomyelitis by modulating IL-17 production by CD4+ T cells.

Yu P, Bamford RN, Waldmann TA.

Eur J Immunol. 2014 Nov;44(11):3330-41. doi: 10.1002/eji.201444675.

8.

IL-15 augments TCR-induced CD4+ T cell expansion in vitro by inhibiting the suppressive function of CD25 High CD4+ T cells.

Van Belle TL, Dooms H, Boonefaes T, Wei XQ, Leclercq G, Grooten J.

PLoS One. 2012;7(9):e45299. doi: 10.1371/journal.pone.0045299. Epub 2012 Sep 20.

9.

Natural CD8+CD122+ T cells are more potent in suppression of allograft rejection than CD4+CD25+ regulatory T cells.

Dai Z, Zhang S, Xie Q, Wu S, Su J, Li S, Xu Y, Li XC.

Am J Transplant. 2014 Jan;14(1):39-48. doi: 10.1111/ajt.12515. Epub 2013 Nov 12.

10.
11.

Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.

Plain KM, Verma ND, Tran GT, Nomura M, Boyd R, Robinson CM, Hodgkinson SJ, Hall BM.

Transpl Immunol. 2013 Dec;29(1-4):51-9. doi: 10.1016/j.trim.2013.10.003. Epub 2013 Oct 16.

PMID:
24139939
12.
13.

Control of T-cell activation by CD4+ CD25+ suppressor T cells.

Shevach EM, McHugh RS, Piccirillo CA, Thornton AM.

Immunol Rev. 2001 Aug;182:58-67. Review.

PMID:
11722623
14.

Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.

Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T.

Immunol Rev. 2006 Aug;212:8-27. Review.

PMID:
16903903
15.

Interleukin-2 and autoimmune disease occurrence and therapy.

Geng X, Zhang R, Yang G, Jiang W, Xu C.

Eur Rev Med Pharmacol Sci. 2012 Oct;16(11):1462-7. Review.

16.

IL-2- and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets.

Létourneau S, Krieg C, Pantaleo G, Boyman O.

J Allergy Clin Immunol. 2009 Apr;123(4):758-62. doi: 10.1016/j.jaci.2009.02.011. Review.

PMID:
19348914
17.

IL-2/α-IL-2 Complex Treatment Cannot Be Substituted for the Adoptive Transfer of Regulatory T cells to Promote Bone Marrow Engraftment.

Mahr B, Unger L, Hock K, Pilat N, Baranyi U, Schwarz C, Maschke S, Farkas AM, Wekerle T.

PLoS One. 2016 Jan 5;11(1):e0146245. doi: 10.1371/journal.pone.0146245. eCollection 2016.

18.

Diphtheria toxin-based bivalent human IL-2 fusion toxin with improved efficacy for targeting human CD25(+) cells.

Peraino JS, Zhang H, Rajasekera PV, Wei M, Madsen JC, Sachs DH, Huang CA, Wang Z.

J Immunol Methods. 2014 Mar;405:57-66. doi: 10.1016/j.jim.2014.01.008. Epub 2014 Jan 24.

19.

[Proliferation of CD4+ CD25+ regulatory T cells of rat by different cytokines in vitro].

Wang ZH, Zhu JY, Li T, Leng XS.

Zhonghua Yi Xue Za Zhi. 2008 Mar 25;88(12):844-7. Chinese.

PMID:
18756991
20.

Supplemental Content

Support Center